Skip to main content
Log in

Antianxiety effect of cannabidiol in the elevated plus-maze

Psychopharmacology Aims and scope Submit manuscript

Cite this article


In order to assess the presence of anxiolytic properties in cannabidiol (CBD) the drug was tested in an elevated plus-maze model of anxiety, in rats. Doses of 2.5, 5.0 and 10.0 mg/kg significantly increased the entry ratio (open/total number of entries), an anxiolytic-like effect. CBD at a dose of 20.0 mg/kg was no longer effective. None of the doses of CBD used changed total number of entries, a measure of total exploratory activity. Diazepam (2.0 mg/kg) also caused an anxiolytic-like effect in this model. These results indicate that CBD causes a selective anxiolytic effect in the elevated plusmaze, within a limited range of doses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions


  • Cunha JM, Carlini EA, Pereira AE, Ramos OL, Pimentel C, Gagliardi R, Sannito WL, Lander N, Mechoulam R (1980) Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology 21:175–185

    Google Scholar 

  • Dewey WL (1986) Cannabidiol pharmacology. Pharmacol Rev 38:151–178

    Google Scholar 

  • Grlie L (1976) A comparative study on some chemical and biological characteristics of various samples of cannabis resin. Bull Narc 14:37–46

    Google Scholar 

  • Pellow S, File SE (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze. A novel test of anxiety in the rat. Pharmacol Biochem Behav 24:525–529

    Google Scholar 

  • Pellow S, Chopin P, File SE, Briley M (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14:149–167

    Google Scholar 

  • Silveira Filho NG, Tufik S (1981) Comparative effects between cannabidiol and diazepam on neophobia, food intake and conflict behavior. Res Commun Psychol Psychiatr Behav 6:25–66

    Google Scholar 

  • Sofia RD, Kubena RK, Barry H (1971) Comparison of four vehicles for intraperitoneal administration of 1-tetrahydrocannabinol. J Pharm Pharmacol 23:889–891

    Google Scholar 

  • Zuardi AW, Karniol IG (1983) Changes in the conditioned emotional response of rats induced by 9-THC, CBD and mixture of the two cannabinoids. Arq Biol Tecnol 26:391–397

    Google Scholar 

  • Zuardi AW, Shirakawa I, Finkelfarb E, Karniol IG (1982) Action of cannabidiol on the anxiety and other effects produced by 9-THC in normal subjects. Psychopharmacology 76:245–250

    Google Scholar 

Download references

Author information

Authors and Affiliations


Rights and permissions

Reprints and Permissions

About this article

Cite this article

Guimarães, F.S., Chiaretti, T.M., Graeff, F.G. et al. Antianxiety effect of cannabidiol in the elevated plus-maze. Psychopharmacology 100, 558–559 (1990).

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI:

Key words